# Pharmacokinetics Study of Liposomal Paclitaxel in Humans

> **NCT00606515** · PHASE4 · COMPLETED · sponsor: **Shandong Luye Pharmaceutical Co., Ltd.** · enrollment: 16 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Liposomal paclitaxel
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00606515
- **Lead sponsor:** Shandong Luye Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2009-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606515, "Pharmacokinetics Study of Liposomal Paclitaxel in Humans". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00606515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*